Vitiligo is the commonest dyspigmentation disorder of skin and/or mucosa, with clinical manifestations of porcelain white patches. It is considered to be a multifactorial disease caused by the destruction of melanocytes. The aim of this study is to estimate serum S100B level and to evaluate its correlation with vitiligo activity and severity. Sixty three patients had vitiligo and twenty healthy volunteers as control group were included in our study. All cases were assessed for severity by VASI score and the disease activity for the last one year. Serum S100B level was estimated in both patient and control groups.
Introduction
Vitiligo is the most common pigmentary disorder of skin and/or mucosa affecting 1-2% of the world's population with clinical manifestations of porcelain white patches (1).
Vitiligo is classified broadly into nonsegmental (NSV) and segmental (SV) vitiligo.
Several subphenotypes of NSV have been described, including mucosal, acrofacial, generalized, and universal (2).
Vitiligo is the result of complex interactions of biochemical, environmental and immunological events, while the precise mechanism of vitiligo pathogenesis has ISSN: 2536-9474 (Print) Original article / FYMJ ISSN: 2536-9482 (Online) Fayoum University Medical Journal Abd-ElRaheem et al., 2019,4( S100B is a member of the family of S100 proteins. S100B is a damage associated molecular pattern protein expressed in melanocytes that has been proposed as a marker of melanocyte cytotoxicity and it is well established in melanoma. (5).
Subjects and Methods
The aim of this study is to estimate serum S100B level and to evaluate its correlation with vitiligo activity and severity. Sixty three patients had vitiligo and twenty healthy volunteers as control group were included in our study. All cases were assessed for severity by VASI score and the disease activity for the last one year. Serum S100B level was estimated in both patient and control groups.
Results
1-This study revealed that there was a statistically significant difference between S100B level in cases and control groups with p-value < 0.05. ISSN: 2536-9474 (Print) Original article / FYMJ ISSN: 2536-9482 (Online) Fayoum University Medical Journal Abd-ElRaheem et al., 2019,4 (1), 86-92
Page 88 2-The study showed highly statistically significant correlation (p<0.001) between the level of S100B protein in serum of cases with disease severity measured by VASI. S100B as a disease activity marker has been widely studied in melanoma indicating melanocyte cytotoxicity (11).
Cases
In our study, there was a statistically significant difference between S100B level in case group and control group with (p-value =0.048). The mean serum S100B for patients was 68.93 ± 77.05, and for control group was 34.06 ± 7.27. There was also a highly ISSN: 2536-9474 (Print) Original article / FYMJ ISSN: 2536-9482 (Online) Fayoum University Medical Journal Abd-ElRaheem et al., 2019,4(1) respectively; p = 0.005), and even showed a marked increase in S100B serum levels in vitiligo patients with highly active vitiligo compared with patients with lower activity statuses (n = 7/89 [7.9%] vs. n = 82/89 [92.1%], respectively; p = 0.008).
Conclusion:
1-S100B could be a potential biomarker for vitiligo activity and severity.
2-Further studies are needed to explore more role of S100B in vitiligo pathogenesis and possible application in treatment stratigies.
